Skip to main content
. Author manuscript; available in PMC: 2017 Feb 14.
Published in final edited form as: Pflugers Arch. 2016 Aug 27;468(10):1685–1695. doi: 10.1007/s00424-016-1873-y

Fig. 1.

Fig. 1

Expression of inducible, mutated cMyBP-C protein. a Schematic diagram showing domain organization and sequences of wild-type cMyBP-C (Wt) and cMyBP-CS2− (m domain; R266, R270, R271 mutated to alanine). b Expression of different lines of the S2- transgene in the S2-xtTA mouse hearts. Representative Western blots using anti-cMyBP-C and anti-c-myc antibodies. α-Sarcomeric actin was used as a loading control. c Western blot analyses of cMyBP-C levels in the heart. To obtain complete replacement of endogenous cMyBP-C with the Tg mutant proteins, the individual cMyBP-CS2−-xtTA double Tg lines were bred into the cMyBP-C−/− background. Transgenic expression of the cMyBP-CS2− protein approximated normal levels of the protein in the Ntg hearts. d Quantitation of transgene expression via Western blotting confirmed equivalent expression of cMyBP-CS2− protein relative to normal cMyBP-C protein in the Ntg hearts